| Code | Description | Claims | Beneficiaries | Total Paid |
| 80053 |
Comprehensive metabolic panel |
7,472 |
6,456 |
$485K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,802 |
5,592 |
$386K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,321 |
10,343 |
$326K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,227 |
2,066 |
$181K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,568 |
3,786 |
$168K |
| 81001 |
|
9,910 |
8,682 |
$138K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,683 |
2,495 |
$122K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,433 |
4,761 |
$118K |
| 81025 |
|
5,677 |
5,129 |
$108K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,373 |
2,370 |
$104K |
| 36415 |
Collection of venous blood by venipuncture |
2,072 |
1,404 |
$78K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
943 |
739 |
$75K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
912 |
859 |
$66K |
| 84702 |
|
2,026 |
1,738 |
$60K |
| 71046 |
Radiologic examination, chest; 2 views |
3,174 |
2,840 |
$57K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,045 |
7,998 |
$55K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,895 |
1,744 |
$47K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,395 |
1,286 |
$42K |
| 87081 |
|
320 |
301 |
$41K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,059 |
1,852 |
$35K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
452 |
414 |
$31K |
| 87210 |
|
656 |
571 |
$30K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,116 |
1,977 |
$24K |
| 86900 |
|
342 |
295 |
$22K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,394 |
1,214 |
$21K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,177 |
4,575 |
$19K |
| 71045 |
Radiologic examination, chest; single view |
3,250 |
2,905 |
$18K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,062 |
968 |
$16K |
| 94010 |
|
97 |
92 |
$15K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
271 |
251 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
898 |
808 |
$12K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,535 |
5,465 |
$12K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,581 |
3,288 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,465 |
10,402 |
$10K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
24 |
24 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
66 |
58 |
$6K |
| 86901 |
|
405 |
348 |
$6K |
| 73560 |
|
166 |
144 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
425 |
391 |
$5K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
332 |
318 |
$5K |
| 87077 |
|
316 |
290 |
$5K |
| 85027 |
|
1,992 |
1,581 |
$4K |
| 73630 |
|
84 |
78 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
195 |
178 |
$4K |
| 86850 |
|
56 |
51 |
$4K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
13 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
443 |
428 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,472 |
2,831 |
$3K |
| 76801 |
|
663 |
553 |
$3K |
| 72100 |
|
129 |
123 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
31 |
26 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,474 |
3,073 |
$2K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
129 |
125 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
64 |
62 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
141 |
137 |
$2K |
| G0378 |
Hospital observation service, per hour |
428 |
275 |
$2K |
| 76642 |
|
53 |
43 |
$2K |
| 73610 |
|
40 |
37 |
$2K |
| 96376 |
|
480 |
318 |
$2K |
| 93017 |
|
66 |
64 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
194 |
163 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,820 |
4,003 |
$1K |
| 81003 |
|
471 |
414 |
$1K |
| J3490 |
Unclassified drugs |
2,569 |
1,742 |
$999.76 |
| 93971 |
|
28 |
27 |
$982.57 |
| 76000 |
|
134 |
126 |
$938.74 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
25 |
24 |
$792.39 |
| 73502 |
|
26 |
26 |
$761.93 |
| 84484 |
|
3,492 |
2,808 |
$731.10 |
| 84443 |
Thyroid stimulating hormone (TSH) |
647 |
596 |
$718.03 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,232 |
4,463 |
$611.37 |
| 73130 |
|
28 |
24 |
$597.21 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
245 |
226 |
$573.98 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,815 |
3,391 |
$537.50 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,168 |
2,768 |
$537.50 |
| 84703 |
|
41 |
38 |
$488.67 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,094 |
989 |
$477.14 |
| 77066 |
Tomosynthesis, mammo |
12 |
12 |
$470.86 |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$465.26 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
526 |
469 |
$444.10 |
| 86140 |
|
135 |
121 |
$387.37 |
| 83690 |
|
3,578 |
3,195 |
$330.91 |
| 85610 |
|
631 |
537 |
$191.19 |
| 80061 |
Lipid panel |
60 |
57 |
$180.35 |
| 74018 |
|
13 |
13 |
$146.94 |
| 86803 |
|
110 |
104 |
$101.20 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,149 |
1,711 |
$74.93 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
399 |
334 |
$58.68 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
277 |
251 |
$48.97 |
| 85018 |
|
17 |
17 |
$26.57 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,312 |
1,973 |
$22.81 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,727 |
5,684 |
$7.93 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
202 |
187 |
$1.01 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
291 |
276 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
441 |
393 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,295 |
1,853 |
$0.00 |
| 94664 |
|
229 |
131 |
$0.00 |
| 87186 |
|
135 |
118 |
$0.00 |
| 80076 |
|
45 |
40 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
60 |
38 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
481 |
401 |
$0.00 |
| 93976 |
|
758 |
677 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
62 |
58 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
279 |
217 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
28 |
25 |
$0.00 |
| 84145 |
|
133 |
119 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
29 |
25 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
39 |
36 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
56 |
54 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
23 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
58 |
44 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
15 |
13 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,531 |
2,284 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
316 |
287 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
254 |
216 |
$0.00 |
| 83880 |
|
358 |
330 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,934 |
1,448 |
$0.00 |
| A9270 |
Non-covered item or service |
1,637 |
1,145 |
$0.00 |
| 87040 |
|
74 |
65 |
$0.00 |
| 83605 |
|
619 |
535 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
502 |
389 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
366 |
308 |
$0.00 |
| 83735 |
|
4,188 |
3,436 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
31 |
26 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
382 |
285 |
$0.00 |
| 85379 |
|
353 |
324 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
962 |
860 |
$0.00 |
| 82550 |
|
249 |
164 |
$0.00 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
549 |
447 |
$0.00 |
| 85730 |
|
258 |
217 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
352 |
285 |
$0.00 |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
105 |
92 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
138 |
133 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
62 |
53 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
50 |
49 |
$0.00 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
14 |
12 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
13 |
$0.00 |